skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
10/13/2020
Application #:
29645873
Filing Dt:
04/30/2018
Inventors:
Michael Denzer, Robert W. Swift, Suhas Krishna, Neal Johnston, Gabriele Ganzitti et al
Title:
PHARMACEUTICAL PRODUCT CASSETTE FOR AN INJECTION DEVICE
Assignment: 1
Reel/Frame:
045670/0169Recorded: 04/30/2018Pages: 7
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
10/27/2011
Exec Dt:
10/21/2011
Exec Dt:
10/26/2011
Assignee:
SUITE 802 ST. JAMES COURT
ST. DENIS STREET
PORT LOUIS, MAURITIUS 11411
Correspondent:
MARSHALL, GERSTEIN & BORUN LLP (AMGEN)
233 SOUTH WACKER DRIVE
6300 WILLIS TOWER
CHICAGO, IL 60606-6357
Assignment: 2
Reel/Frame:
045670/0054Recorded: 04/30/2018Pages: 12
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
02/11/2014
Exec Dt:
02/03/2014
Exec Dt:
02/03/2014
Assignee:
ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CALIFORNIA 91320
Correspondent:
MARSHALL, GERSTEIN & BORUN LLP (AMGEN)
233 SOUTH WACKER DRIVE
6300 WILLIS TOWER
CHICAGO, IL 60606-6357
Assignment: 3
Reel/Frame:
045670/0341Recorded: 04/30/2018Pages: 4
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
03/21/2014
Assignee:
ONE AMGEN CENTER DRIVE
THOUSAND OAKS, CALIFORNIA 91320
Correspondent:
MARSHALL, GERSTEIN & BORUN LLP (AMGEN)
233 SOUTH WACKER DRIVE
6300 WILLIS TOWER
CHICAGO, IL 60606-6357

Search Results as of: 05/14/2024 01:15 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT